Health and Healthcare

Latest Articles

All Latest Articles

149398 Articles

Chris Lange | Jun 27, 2018 at 1:30 PM EDT

Short Sellers Can’t Make Up Their Minds on Major Oil

The June 15 short interest data have been compared with the previous figures, and short interest in these selected big…

Paul Ausick | Jun 27, 2018 at 1:20 PM EDT

Molson Coors Reported Seeking Partner for Cannabis-Infused Brew

Beermaker Molson Coors has reportedly been talking to marijuana growers about teaming up to offer a cannabis-infused beer. It won't…

Chris Lange | Jun 27, 2018 at 1:15 PM EDT

Are Major Banks Signalling Optimism With Short Interest Report?

The June 15 short interest data have been compared with the previous figures, and short interest in these selected big…

Chris Lange | Jun 27, 2018 at 1:05 PM EDT

Short Sellers Hike Bets in Major Pharma Stocks

The June 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jun 27, 2018 at 12:40 PM EDT

Short Sellers Grow More Selective on Cybersecurity Stocks

The June 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Jun 27, 2018 at 12:10 PM EDT

Pain Therapeutics Shares Reeling After FDA Vote

Pain Therapeutics shares were destroyed on Wednesday after a vote from the FDA was announced.

Chris Lange | Jun 27, 2018 at 12:05 PM EDT

Why the US Could Lose Big If Trump Imposes Auto Tariffs

Trade wars ultimately hurt all parties involved in one way or another, and with the U.S. president threatening heavy tariffs…

Paul Ausick | Jun 27, 2018 at 12:00 PM EDT

May Pending Home Sales Tick Higher, Inventory Remains a Problem

The National Association of Realtors reported Wednesday morning the pending home sales in May rose by 0.5%. Rising prices for…

Jon C. Ogg | Jun 27, 2018 at 11:55 AM EDT

How a New Gout Drug Could Lead to 100% to 200% Upside

Janney Montgomery Scott has initiated coverage of Selecta Biosciences with a price target that represents huge upside.

Chris Lange | Jun 27, 2018 at 11:45 AM EDT

Cara Therapeutics Wins Big With Abdominal Pain Trial

Cara Therapeutics shares made a solid gain on Wednesday after the biotech announced positive results from a midstage trial.

Trey Thoelcke | Jun 27, 2018 at 11:40 AM EDT

The 6 Most Shorted Nasdaq Stocks

Judging by the most shorted stocks traded on the Nasdaq between the May 31 and June 15 settlement dates, those…

Paul Ausick | Jun 27, 2018 at 11:25 AM EDT

Crude Oil Price Pops on Huge Inventory Draw

U.S. crude oil stockpiles fell by nearly 10 million barrels last week, significantly more than analysts' projected, and the price…

Chris Lange | Jun 27, 2018 at 11:20 AM EDT

Lovesac Enters the Market With a Bang

The Lovesac Co. (NASDAQ: LOVE) entered the market with a bang on Wednesday in its initial public offering (IPO). The…

Jon C. Ogg | Jun 27, 2018 at 11:10 AM EDT

Why One Analyst Believes AT&T Shares Have Finally Bottomed Out

One key analyst on Wall Street believes the AT&T deal for Time Warner will not hurt shareholders further, and he…

Paul Ausick | Jun 27, 2018 at 10:40 AM EDT

India Is the World’s Most Dangerous Country for Women

India is the world's most dangerous country for women according to a new survey from the Thomson Reuters Foundation. An…

1 … 4,294 4,295 4,296 4,297 4,298 … 9,960

Latest Articles

All Latest Articles

Short Sellers Can’t Make Up Their Minds on Major Oil

Molson Coors Reported Seeking Partner for Cannabis-Infused Brew

Are Major Banks Signalling Optimism With Short Interest Report?

Short Sellers Hike Bets in Major Pharma Stocks

Short Sellers Grow More Selective on Cybersecurity Stocks

Pain Therapeutics Shares Reeling After FDA Vote

Why the US Could Lose Big If Trump Imposes Auto Tariffs

May Pending Home Sales Tick Higher, Inventory Remains a Problem

How a New Gout Drug Could Lead to 100% to 200% Upside

Cara Therapeutics Wins Big With Abdominal Pain Trial

The 6 Most Shorted Nasdaq Stocks

Crude Oil Price Pops on Huge Inventory Draw

Lovesac Enters the Market With a Bang

Why One Analyst Believes AT&T Shares Have Finally Bottomed Out

India Is the World’s Most Dangerous Country for Women

History Says This Unstoppable Dow Juggernaut Is a No-Brainer Buy Right Now

Lucid Stock Is Deeply Oversold and We See 45% Gains Ahead

The $1,847 Monthly Survivor Benefit Most Widows Leave on the Table by Filing at the Wrong Age

The $1,847 Monthly Survivor Benefit Most Widows Leave on the Table by Filing at the Wrong Age

The West's Home Prices Just Fell 1.4% While the Rest of America Climbed. Here's Why.

History Says This Unstoppable Dow Juggernaut Is a No-Brainer Buy Right Now

Lucid Stock Is Deeply Oversold and We See 45% Gains Ahead

Latest Articles

All Latest Articles

Short Sellers Can’t Make Up Their Minds on Major Oil

Molson Coors Reported Seeking Partner for Cannabis-Infused Brew

Are Major Banks Signalling Optimism With Short Interest Report?

Short Sellers Hike Bets in Major Pharma Stocks

Short Sellers Grow More Selective on Cybersecurity Stocks

Pain Therapeutics Shares Reeling After FDA Vote

Why the US Could Lose Big If Trump Imposes Auto Tariffs

May Pending Home Sales Tick Higher, Inventory Remains a Problem

How a New Gout Drug Could Lead to 100% to 200% Upside

Cara Therapeutics Wins Big With Abdominal Pain Trial

The 6 Most Shorted Nasdaq Stocks

Crude Oil Price Pops on Huge Inventory Draw

Lovesac Enters the Market With a Bang

Why One Analyst Believes AT&T Shares Have Finally Bottomed Out

India Is the World’s Most Dangerous Country for Women

History Says This Unstoppable Dow Juggernaut Is a No-Brainer Buy Right Now

Lucid Stock Is Deeply Oversold and We See 45% Gains Ahead

The $1,847 Monthly Survivor Benefit Most Widows Leave on the Table by Filing at the Wrong Age

Featured Reads

The $1,847 Monthly Survivor Benefit Most Widows Leave on the Table by Filing at the Wrong Age

The West's Home Prices Just Fell 1.4% While the Rest of America Climbed. Here's Why.